CIA
AZN icon

Cohen Investment Advisors’s AstraZeneca AZN Stock Holding History

Cohen Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$674K Buy
3,602
+45
+1% +$8.46K 0.3% 52
2026
Q1 		$689K Sell
3,557
-31
-0.9% -$5.98K 0.33% 49
2025
Q4 		$660K Sell
3,588
-52
-1% -$9.12K 0.3% 48
2025
Q3 		$558K Buy
3,640
+138
+4% +$20.9K 0.27% 51
2025
Q2 		$489K Sell
3,502
-146
-4% -$20.5K 0.26% 54
2025
Q1 		$536K Buy
3,648
+33
+0.9% +$4.77K 0.31% 51
2024
Q4 		$474K Buy
3,615
+130
+4% +$18.2K 0.29% 56
2024
Q3 		$543K Sell
3,485
-777
-18% -$125K 0.33% 49
2024
Q2 		$577K Buy
4,262
+460
+12% +$69.2K 0.46% 46
2024
Q1 		$515K Sell
3,802
-141
-4% -$18.7K 0.33% 50
2023
Q4 		$531K Sell
3,943
-319
-7% -$41.5K 0.39% 49
2023
Q3 		$577K Sell
4,262
-304
-7% -$41.5K 0.46% 46
2023
Q2 		$654K Hold
4,566
– – 0.53% 45
2023
Q1 		$634K Sell
4,566
-35
-0.8% -$4.71K 0.5% 46
2022
Q4 		$624K Buy
4,601
+156
+4% +$19.6K 0.52% 45
2022
Q3 		$487K Sell
4,445
-244
-5% -$31K 0.45% 49
2022
Q2 		$620K Sell
4,689
-58
-1% -$7.61K 0.53% 44
2022
Q1 		$630K Buy
4,747
+46
+1% +$5.52K 0.47% 47
2021
Q4 		$548K Sell
4,701
-4
-0.1% -$471 0.39% 50
2021
Q3 		$565K Buy
4,705
+16
+0.3% +$1.86K 0.43% 47
2021
Q2 		$562K Buy
4,689
+20
+0.4% +$2.19K 0.44% 45
2021
Q1 		$464K Sell
4,669
-42
-0.9% -$4.22K 0.38% 49
2020
Q4 		$471K Buy
+4,711
New +$499K 0.43% 47

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cohen Investment Advisors's AZN Position: Q2 2026 in Review

Cohen Investment Advisors increased its AstraZeneca (AZN) stake by 1.3% in Q2 2026, buying an estimated $8.46K and bringing the position to 3,602 shares worth $674K. The position accounts for 0.3% of the portfolio, ranked #52.

Cohen Investment Advisors first reported a position in AZN in Q4 2020 and has held it in 23 quarters since. The position peaked at $689K in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Cohen Investment Advisors held 3,602 shares of AstraZeneca worth $674K as of Q2 2026.
  • Cohen Investment Advisors bought 45 AstraZeneca shares in Q2 2026, an estimated $8.46K.
  • AstraZeneca made up 0.3% of Cohen Investment Advisors's portfolio in Q2 2026, its #52 holding.
  • Cohen Investment Advisors first reported a position in AstraZeneca in Q4 2020 and has held it in 23 quarters since.
  • Cohen Investment Advisors's AstraZeneca position peaked at $689K in Q1 2026.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cohen Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.